News
Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...
Records show that a top U.S. regulator rejected the recommendations of agency experts and limited the use of Covid vaccines.
The answer is that the “big, beautiful” bill reveals Trump’s true colors. He is more committed to surreptitiously gamblin g ...
The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.
A new study reveals that the same clinical signs of depression may stem from different brain profiles, highlighting both ...
A line from Trump’s speech to Congress had ripple effects on health research funding for everything from HIV to asthma to ...
Patients with migraine discontinued treatment less often with atogepant and experienced a greater reduction in mean monthly ...
Despite recent ASCO and FDA guidance recommending the inclusion of people living with HIV in pivotal cancer trials, nearly 75 ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
The study assessed 461 urgent care virtual visits from June 12 through July 14, 2024. Adult patients entered their medical concerns and provided demographic information on a mobile app.
A novel study aimed at disentangling the neurological underpinnings of depression shows that multiple brain profiles may ...
A novel study aimed at disentangling the neurological underpinnings of depression shows that multiple brain profiles may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results